AstraZeneca reports 1.55 billion shares with voting rights
AstraZeneca has announced its total issued share capital as of October 31, 2026, confirming 1,551,065,237 ordinary shares with voting rights.
AstraZeneca PLC confirmed on November 2, 2026, that its issued share capital consists of 1,551,065,237 ordinary shares of US$0.25 each. The company stated that no shares are currently held in treasury.
The disclosure, made in compliance with the UK Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1, establishes the definitive figure for shareholders. This total serves as the denominator for investors assessing their notification requirements regarding holdings in the company.
This update provides the official share count as of the October 31 reporting deadline, maintaining transparency regarding the company’s capital structure for market participants.